o2h discovery
Dr. Pradip Patel is a highly experienced professional in the pharmaceutical industry with a focus on drug discovery and development. Currently serving as Senior Group Leader 1 at o2h discovery since April 2017, Dr. Patel has held multiple leadership roles within the company. Prior to this, significant contributions were made at Piramal Pharma Solutions from November 2012 to March 2017 as a Senior Research Scientist and at Evotec as a Scientist-1 from January 2011 to October 2012, where expertise was gained in small molecule drug development. Dr. Patel's career also includes a tenure at Jubilant Chemsys as a Senior Research Associate and as a Trainee Research Associate at Dishman. Academic credentials include a PhD in organic chemistry from Banasthali Vidyapith, obtained between 2007 and 2011.
o2h discovery
Founded in 2005, o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. o2h discovery has developed and launched its proprietary application Chemistry in the Cloud™ (CITC), the world’s first app to revolutionize the project management of external drug discovery programs. The app enables communication between various scientific stakeholders essential to successful project advancement – leading to faster decision making. The DNA of o2h discovery is centered around the nurturing of its people, values, and culture. It reflects in the way we work with each other, as well as our collaborators and partners. For more information about o2h group, please visit www.o2h.com and to know more about our chemistry & biology services, please see – https://o2hdiscovery.co